N Engl J Med 371 (2): 107-18, 2014.[PUBMED Abstract] Francis PA, Fleming GF, LÃ¡ng I, et al.: Adjuvant Endocrine Therapy in Premenopausal Breast Cancer: 12-Year Results From SOFT.
J Clin Oncol 41 (7): 1370-1375, 2023.[PUBMED Abstract] Bernhard J, Luo W, Ribi K, et al.: Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): a combined analysis of two phase 3 randomised trials.
Lancet Oncol 16 (7): 848-58, 2015.[PUBMED Abstract] Dowsett M, Forbes JF, Bradley R, et al.: Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials.